June 2014 FDA Recall Heparin Sodium And Dextrose by Hospira Inc.
D-1425-2014 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Hospira Inc. on June 6, 2014 for the product Heparin Sodium And Dextrose. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1425-2014

Reason for Recall
Lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag.
Initiated
06-06-2014
Reported
07-16-2014
Quantity
142,152 bags

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL, Single-Dose Container, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-7793-62

Batch or Lot Expiration Information

Lot# 34-811-KL, 36-106-KL, 36-114-KL; Exp. 12/15; 36-101-KL, Exp. 12/15; 37-202-KL, Exp. 1/16; 38-302-KL, Exp. 2/16; 38-305-KL, Exp. 2/16